share_log

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga ·  Mar 8 12:31

Gainers

  • Psyence Biomedical (NASDAQ:PBM) stock moved upwards by 137.8% to $3.02 during Friday's regular session. The market value of their outstanding shares is at $40.4 million.
  • Ainos (NASDAQ:AIMD) stock moved upwards by 91.96% to $2.15. The company's market cap stands at $10.0 million.
  • Mira Pharmaceuticals (NASDAQ:MIRA) shares increased by 34.75% to $1.28. The company's market cap stands at $18.9 million.
  • Joint (NASDAQ:JYNT) stock rose 29.1% to $11.8. The market value of their outstanding shares is at $174.1 million. The company's, Q4 earnings came out yesterday.
  • Lantern Pharma (NASDAQ:LTRN) stock rose 25.11% to $8.32. The market value of their outstanding shares is at $89.3 million.
  • Grifols (NASDAQ:GRFS) stock increased by 19.69% to $6.71. The market value of their outstanding shares is at $4.5 billion.

Losers

  • Amylyx Pharma (NASDAQ:AMLX) shares declined by 81.5% to $3.52 during Friday's regular session. The market value of their outstanding shares is at $238.2 million.
  • Immuron (NASDAQ:IMRN) stock fell 25.94% to $3.37. The market value of their outstanding shares is at $19.1 million.
  • Jin Medical International (NASDAQ:ZJYL) shares fell 22.94% to $7.09. The company's market cap stands at $1.1 billion.
  • eFFECTOR Therapeutics (NASDAQ:EFTR) shares fell 16.55% to $12.51. The market value of their outstanding shares is at $42.7 million.
  • CASI Pharmaceuticals (NASDAQ:CASI) stock declined by 14.27% to $4.84. The market value of their outstanding shares is at $64.4 million.
  • Turnstone Biologics (NASDAQ:TSBX) stock declined by 13.72% to $3.46. The market value of their outstanding shares is at $79.9 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment